HOOKIPA Pharma Inc. (HOOK)
OTCMKTS · Delayed Price · Currency is USD
1.190
0.00 (0.00%)
At close: May 18, 2026
HOOKIPA Pharma Revenue
HOOKIPA Pharma had revenue of $2.00M in the quarter ending March 31, 2025, a decrease of -94.52%. This brings the company's revenue in the last twelve months to $9.35M, down -82.54% year-over-year. In the year 2024, HOOKIPA Pharma had annual revenue of $43.95M with 118.32% growth.
Revenue (ttm)
9.35M
Revenue Growth
-82.54%
P/S Ratio
1.64
Revenue / Employee
110.01K
Employees
87
Market Cap
15.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43.95M | 23.82M | 118.32% |
| Dec 31, 2023 | 20.13M | 5.88M | 41.27% |
| Dec 31, 2022 | 14.25M | -4.20M | -22.76% |
| Dec 31, 2021 | 18.45M | -1.14M | -5.80% |
| Dec 31, 2020 | 19.58M | 7.64M | 63.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHOOKIPA Pharma News
- 3 months ago - Hookipa Pharma announces sale of oncology assets to NeoTrail Therapeutics - TheFly
- 3 months ago - HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics - GlobeNewsWire
- 7 months ago - Hookipa Pharma completes sale of HBV, HIV assets to Gilead - TheFly
- 7 months ago - HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead - GlobeNewsWire
- 10 months ago - Hookipa Pharma to delist shares from Nasdaq - TheFly
- 10 months ago - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - GlobeNewsWire
- 1 year ago - HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewsWire
- 1 year ago - Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial - TheFly